American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Tallman
    Tallman
  5. Perales
    Perales
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Kernan
    Kernan
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3844)
  2. Hematologic Malignancies, Division of (3639)
  3. Center for Hematologic Malignancies (3542)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1289)
  6. Sloan Kettering Institute Faculty (1065)
  7. Bone Marrow Transplant (936)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (931)
  9. Lymphoma (898)
  10. Tow Center for Developmental Oncology (TCDO) (863)
Search Within
Formats
  1. Meeting Abstract (3939)
  2. Journal Article (1239)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3844)
  2. Hematologic Malignancies, Division of (3639)
  3. Center for Hematologic Malignancies (3542)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1289)
  6. Sloan Kettering Institute Faculty (1065)

More Groups

People
  1. Sergio Giralt (337)
  2. Andrew Zelenetz (328)
  3. Ross Levine (312)
  4. Martin Tallman (298)
  5. Miguel-Angel Perales (292)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (43)
  2. 2024 (217)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (4951)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5323)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Implications of minimal residual disease negative complete remission (MRD-CR) and allogeneic stem cell transplant on safety and clinical outcome of CD19 targeted 19-28z CAR modified T cells in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Wang, Y.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Diverse mechanisms of vemurafenib resistance in BRAF-mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Durham, B.; Chung, Y. R.; Scott, S.; Getta, B.; Kim, E.; Saven, A.; Stone, R. M.; Rai, K. R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • IKZF2, a novel target of MSI2 RNA-binding protein plays an oncogenic role in myeloid leukemia
    Meeting Abstract

    Park, S. M.; Thornton, A.; Vu, L. P.; Chhangawala, S.; Minuesa, G.; Barlowe, T.; Taggart, J.; Tivnan, P.; Kim, T.; Shevach, E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • The abundance of certain bacteria in the intestinal flora is associated with relapse after allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Peled, J.; Littmann, E. R.; Ling, L. L.; Kosuri, S.; Maloy, M.; Giralt, S. A.; Barker, J. N.; Perales, M. A.; Taur, Y.; Pamer, E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Effects of obesity on the efficacy and toxicity of induction chemotherapy in adult acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Peterson, T. J.; Lin, A.; Hilden, P.; Devlin, S.; Adel, N. G.; Park, J. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Rejuvenation of aged vascular niches to enhance hematopoietic function
    Meeting Abstract

    Poulos, M. G.; Gutkin, M.; Park, C. Y.; Butler, J. M.
    Blood (2015)

    Fulltext@MSK | Save
  • PHF6-somatic mutations and their role in pathophysiology of MDS and AML
    Meeting Abstract

    Przychodzen, B.; Gu, X. R.; You, D. W.; Hirsch, C. M.; Clemente, M. J.; Viny, A. D.; Levine, R. L.; Haferlach, T.; Maggendorfer, M.; Sekeres, M. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Therapeutic targeting of spliceosomal mutant myeloid leukemias through modulation of splicing catalysis
    Meeting Abstract

    Lee, S. C. W.; Dvinge, H.; Kim, E.; Cho, H. N.; Chung, Y. R.; Micol, J. B.; Durham, B.; Kim, Y. J.; Thomas, M.; Lobry, C.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Novel alkylating agent, ureidomustine exhibit pre-clinical efficacy in B-cell lymphoma with minimal dose-limiting myelotoxicity
    Meeting Abstract

    Lopes, E. C.; Shieh, J. H.; Ambati, S.; Tsann-Long, S.; Correa, F.; Peguero, E.; Moore, M. A. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Tipifarnib as maintenance therapy in acute myeloid leukemia (AML) improves survival in a subgroup of patients with high risk disease. Results of the phase III intergroup trial E2902
    Meeting Abstract

    Luger, S.; Wang, V. X.; Paietta, E.; Ketterling, R. P.; Rybka, W.; Lazarus, H. M.; Litzow, M. R.; Rowe, J. M.; Larson, R. A.; Appelbaum, F. R.; more...
    Blood (2015)

    Fulltext@MSK | Save